Smith & Nephew is to offer a no-frills service to joint customers in the U.S., but what this amounts to other than not having the rep in attendance, is unclear.
Codman Neuro has chosen the SNIS meeting at which to launch the ENVOY® DA XB Distal Access Guiding Catheter and the 7F ENVOY® Guiding Catheter for neurovascular procedures.
Italian cardiovascular device maker Sorin Group, has gained U.S. FDA approval for the Solo Smart™ Aortic Pericardial Heart Valve which the company claims is the first biological valve to feature a fully removable stent.
Medtronic, Inc. has completed the acquisition of Visualase, Inc., and its FDA-approved MRI-guided laser and image guided system for minimally invasive neurosurgery.
Medtronic has based its new device on the design principles of its successful predecessor, but a few changes of approach and material represent evolutionary steps.
Sales ramped 4% compared with the equivalent period a year ago, but an increase in estimates of costs from pelvic mesh products liability cases saw S,G&A expenses ramp.
Cynosure, Inc., has received FDA 510(k) clearance for its flagship PicoSure Picosecond Laser Workstation for the treatment of acne scars.
Cardiovascular device specialist Sorin Group, has gained CE mark certification for its innovative CROWN PRT™ stented aortic bioprosthesis.
K2M has gained U.S. marketing clearance for its CASPIAN® Occipital Anchor Spinal System and has also announced other product introductions across the globe.
Boston Scientific's Agent™ Paclitaxel-Coated PTCA Balloon Catheter has gained CE mark approval and will now be launched in Europe.
Take out the $750 million settlement from Medtronic and Edwards would still be happy with a healthy sales increase over the equivalent quarter a year ago.
Teleflex subsidiary Hotspur Technologies has gained FDA clearance for its 150cm length Arrow GPSCath dual function balloon dilatation catheters.
Animal testing may soon be a thing of the past if Emulate, Inc., can successfully bring its human bioemulation technology to market.
Atrial Fibrillation specialist AtriCure, Inc. has announced financial results for the second quarter of 2014.
This week we amuse ourselves drawing parallels between the way behaviour was monitored in Venetian colonies during the fourteenth century, and regulation of today's medical device industry.